MedPath

Study for the clinical effect evaluation of strengthening spleen and lowering the stomach Qi therapy for reflux esophagitis with spleen deficiency

Not Applicable
Recruiting
Conditions
reflux esophagitis
Registration Number
ITMCTR1900002514
Lead Sponsor
Dong Fang Hospital, Beijing University of Chinese Medicine
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
Not specified
Inclusion Criteria

1) Clinical diagnosis of Western medicine in accordance with reflux esophagitis, endoscopic in accordance with the diagnosis of reflux esophagitis;
2) in line with reflux esophagitis TCM deficiency gas inverse syndrome (spleen deficiency type) diagnosis;
3) Male and female aged 18-65 years old, voluntarily signed the subject's informed consent.

Exclusion Criteria

1. Anti-acid and heartburn caused by severe organic lesions and other diseases or drugs;
2. Persons with disabilities under the law (blindness, deafness, mute, intellectual impairment, physical disability);
3. Pregnant or prepared for pregnancy, lactating women;
4. Allergic physique or allergic to research drug ingredients;
5. Suspected or indeed has a history of alcohol and substance abuse;
6. Patients who have participated in other clinical studies within 3 months;
7. Patients who have used the relevant therapeutic drugs within 1 months;
8. Unclear description of self-symptoms or investigation of non-authors;
9. with cardiac achalasia, esophageal fissure hernia, high intestinal obstruction and gastrointestinal surgery history;
10. with tumor, digestive system ulcer and other sexual diseases;
11. with hepatobiliary and pancreatic diseases, pregnancy, connective tissue disease and serious systemic diseases;
12. with circulatory system, nervous system, urinary tract and other serious primary diseases and mental patients;
13. take drugs that can cause anti-acid or heartburn symptoms.

Study & Design

Study Type
Interventional study
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Ghrelin;VIP;motilin;
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath